VIRTUAL LIBRARY
PHARMACOTHERAPY
Antidepressants and Body Weight: A Comprehensive Review and Meta-Analysis
Effects of Low-Dose, Controlled-Release, Phentermine Plus Topiramate Combination on Weight and Associated Comorbidities in Overweight and Obese Adults
Naltrexone/Bupropion for Obesity: An Investigational Combination Pharmacotherapy for Weight Loss
Effect of Naltrexone Plus Bupropion on Weight Loss in Overweight and Obese Adults
Obesity Drug Development Targets
Effectiveness and Value of Treatment Options for Obesity
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
3 Years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-Related Risk Factors
New Medications for Treatment of Obesity: Metabolic and Cardiovascular Effects
Obesity Pharmacotherapy
Anti-obesity drugs: past, present and future
Pharmacotherapy for obesity
Pharmacotherapy for Obesity
Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice
Pharmacotherapy in Conjunction with a Diet and Exercise Program for the Treatment ofWeight Recidivism orWeight Loss Plateau Post-bariatric Surgery
POMC Naltrexone
Prescription Medications and Weight Gain
the future of obesity treatment
Weight loss with Naltrexone SR/Bupropion SR combination Therapy as an adjunct to Behaviour modification